Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: a randomized, placebo-controlled, cross-over study (EMSCAP study).
Koch BC, Nagtegaal JE, Hagen EC, van der Westerlaken MM, Boringa JB, Kerkhof GA, Ter Wee PM. Koch BC, et al. Among authors: van der westerlaken mm. Br J Clin Pharmacol. 2009 Jan;67(1):68-75. doi: 10.1111/j.1365-2125.2008.03320.x. Epub 2008 Nov 17. Br J Clin Pharmacol. 2009. PMID: 19076157 Free PMC article. Clinical Trial.
Long-term effects of melatonin on quality of life and sleep in haemodialysis patients (Melody study): a randomized controlled trial.
Russcher M, Koch BC, Nagtegaal JE, van Ittersum FJ, Pasker-de Jong PC, Hagen EC, van Dorp WT, Gabreëls B, Wildbergh TX, van der Westerlaken MM, Gaillard CA, Ter Wee PM. Russcher M, et al. Among authors: van der westerlaken mm. Br J Clin Pharmacol. 2013 Nov;76(5):668-79. doi: 10.1111/bcp.12093. Br J Clin Pharmacol. 2013. PMID: 23432361 Free PMC article. Clinical Trial.
The effects of kidney transplantation on sleep, melatonin, circadian rhythm and quality of life in kidney transplant recipients and living donors.
Russcher M, Nagtegaal JE, Nurmohamed SA, Koch BC, van der Westerlaken MM, van Someren EJ, Bakker SJ, Ter Wee PM, Gaillard CA. Russcher M, et al. Among authors: van der westerlaken mm. Nephron. 2015;129(1):6-15. doi: 10.1159/000369308. Epub 2014 Dec 18. Nephron. 2015. PMID: 25531829 Free article. Clinical Trial.
A multifaceted intervention to reduce drug-related complications in surgical patients.
Bos JM, van den Bemt PM, Kievit W, Pot JL, Nagtegaal JE, Wieringa A, van der Westerlaken MM, van der Wilt GJ, de Smet PA, Kramers C. Bos JM, et al. Among authors: van der westerlaken mm. Br J Clin Pharmacol. 2017 Mar;83(3):664-677. doi: 10.1111/bcp.13141. Epub 2016 Nov 10. Br J Clin Pharmacol. 2017. PMID: 27670813 Free PMC article.
[No advantage to referring patients with acute myocardial infarction from a general hospital to an intervention clinic for percutaneous coronary intervention; comparison of mortality rates in 2000 and 2003 in the Meander Medical Centre, Amersfoort].
Tabbers FC, Nagtegaal JE, Landman MA, van der Westerlaken MM. Tabbers FC, et al. Among authors: van der westerlaken mm. Ned Tijdschr Geneeskd. 2006 Dec 9;150(49):2705-10. Ned Tijdschr Geneeskd. 2006. PMID: 17194008 Dutch.
Erlotinib and pantoprazole: a relevant interaction or not?
Ter Heine R, Fanggiday JC, Lankheet NA, Beijnen JH, Van Der Westerlaken MM, Staaks GH, Malingré MM. Ter Heine R, et al. Among authors: van der westerlaken mm. Br J Clin Pharmacol. 2010 Dec;70(6):908-11. doi: 10.1111/j.1365-2125.2010.03748.x. Br J Clin Pharmacol. 2010. PMID: 21175447 Free PMC article.
Fatal interstitial lung disease associated with high erlotinib and metabolite levels. A case report and a review of the literature.
ter Heine R, van den Bosch RT, Schaefer-Prokop CM, Lankheet NA, Beijnen JH, Staaks GH, van der Westerlaken MM, Malingré MM, van den Brand JJ. ter Heine R, et al. Among authors: van der westerlaken mm. Lung Cancer. 2012 Mar;75(3):391-7. doi: 10.1016/j.lungcan.2011.10.008. Epub 2011 Nov 17. Lung Cancer. 2012. PMID: 22101147 Review.
Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases.
ter Heine R, Lange R, Breukels OB, Bloemendal HJ, Rummenie RG, Wakker AM, de Graaf H, Beekman FJ, van der Westerlaken MM, Malingré MM, Wielders JP, van den Berg L, Hendrikse NH, de Klerk JM. ter Heine R, et al. Among authors: van der westerlaken mm. Int J Pharm. 2014 Apr 25;465(1-2):317-24. doi: 10.1016/j.ijpharm.2014.01.034. Epub 2014 Feb 19. Int J Pharm. 2014. PMID: 24560635
13 results